EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Polymer Nanoparticles in Medical Applications—Future Directions

Barbara Zawidlak-Węgrzyńska iD, Joanna Rydz iD

Nanomaterials · 19.05.2026 · 16 (10) · 630

DOI: 10.3390/nano16100630 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 19.05.2026. Verfasst von Barbara Zawidlak-Węgrzyńska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Medicine in Zabrze, Academy of Silesia, 40-555 Katowice, Poland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymer-based nanoparticle systems have emerged as a versatile platform for advancing precision medicine by enabling controlled, targeted, and multifunctional drug delivery. This narrative review synthesizes recent progress in the design, functionalization, and clinical translation of polymer-based nanoparticles, with a focused scope on drug delivery, diagnostics, theranostics, nanosponges, and regenerative medicine. Specifically, it highlights three key insights: (i) surface engineering strategies, including ligand conjugation and stealth coatings, substantially enhance targeting specificity and reduce off-target toxicity; (ii) stimulus-responsive polymers enable spatiotemporally controlled drug release, improving therapeutic outcomes in complex disease microenvironments; and (iii) integration with artificial intelligence (AI) supports the rational design of personalized nanomedicines based on patient-specific molecular profiles. The innovative nature of this review lies in its comprehensive approach, which combines material design parameters with clinical outcomes and the barriers to implementation. Despite significant progress, serious challenges remain, including scalable and reproducible manufacturing, regulatory harmonization, and comprehensive long-term biosafety assessment. In the future, the priority should be to develop reliable manufacturing processes, a harmonized regulatory framework, and data-driven, clinically validated design methodologies. Overall, polymer-based nanoparticles are poised to redefine targeted therapy, but their clinical impact will depend on bridging the gap between laboratory innovation and scalable, safe, and personalized medical applications.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencebiomedicinediagnosticsnanoparticlesnanospongespersonalized medicinepolymer-based nanomaterialsregenerative medicinetheranostics

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Medicine in Zabrze, Academy of Silesia, 40-555 Katowice, Poland.
  • Centre of Polymer and Carbon Materials, Polish Academy of Sciences, 41-819 Zabrze, Poland.

ORCID-Profile: Barbara Zawidlak-Węgrzyńska, Joanna Rydz

Zitieren

APA

Zawidlak-Węgrzyńska, B., & Rydz, J. (2026). Polymer Nanoparticles in Medical Applications—Future Directions. Nanomaterials, 16(10), 630. https://doi.org/10.3390/nano16100630

Vancouver

Zawidlak-Węgrzyńska B, Rydz J. Polymer Nanoparticles in Medical Applications—Future Directions. Nanomaterials. 2026;16(10):630. doi:10.3390/nano16100630

BibTeX
@article{ZawidlakWgrzyska2026,
  author = {Zawidlak-Węgrzyńska, Barbara and Rydz, Joanna},
  title = {Polymer Nanoparticles in Medical Applications—Future Directions},
  journal = {Nanomaterials},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {630},
  doi = {10.3390/nano16100630}
}
Kostenlos starten →